1 Min Read
Jan 12 (Reuters) - Starpharma Holdings Ltd
* granted qualified infectious disease product (qidp) and fast track designation for vivagel bv by US Food and Drug Administration (FDA). Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.